1. Strobilanthes crispus inhibits migration, invasion and metastasis in breast cancer
- Author
-
Nik Soriani Yaacob, Yusha’u Shu’aibu Baraya, and Kah Keng Wong
- Subjects
Vascular Endothelial Growth Factor A ,Antineoplastic Agents ,Breast Neoplasms ,Vimentin ,Biology ,Metastasis ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Breast cancer ,Cell Movement ,In vivo ,Acanthaceae ,Cell Line, Tumor ,Drug Discovery ,medicine ,Animals ,Humans ,MUC1 ,Cell Proliferation ,030304 developmental biology ,Pharmacology ,Mice, Inbred BALB C ,Wound Healing ,0303 health sciences ,Plant Extracts ,Cell growth ,Mucin-1 ,Twist-Related Protein 1 ,Cancer ,Cadherins ,medicine.disease ,Plant Leaves ,Vascular endothelial growth factor ,Matrix Metalloproteinase 9 ,chemistry ,030220 oncology & carcinogenesis ,Cancer research ,biology.protein ,Female ,Phytotherapy - Abstract
Ethnopharmacological relevance Strobilanthes crispus (L.) Blume, locally known in Malaysia as “Pecah kaca” or “Jin batu”, has been traditionally used for treatment of various ailments including cancer. We previously demonstrated that a standardized bioactive subfraction of S. crispus, termed as F3, possessed potent anticancer effects in both in vitro and in vivo breast cancer models. Aim of the study To investigate the potential of F3 from S. crispus to prevent metastasis in breast cancer. Materials and methods The antimetastatic effects of F3 were first investigated on murine 4T1 and human MDA-MB-231 breast cancer cell (BCC) lines using cell proliferation, wound healing and invasion assays. A 4T1-induced mouse mammary carcinoma model was then used to determine the expression of metastasis tumor markers, epithelial (E)-cadherin, matrix metalloproteinase (MMP)-9, mucin (MUC)-1, nonepithelial (N)-cadherin, Twist, vascular endothelial growth factor (VEGF) and vimentin, using immunohistochemistry, following oral treatment with F3 for 30 days. Results Significant growth arrest was observed with F3 IC50 values of 84.27 µg/ml (24 h) and 74.41 µg/ml (48 h) for MDA-MB-231, and 87.35 µg/ml (24 h) and 78.75 µg/ml (48 h) for 4T1 cells. F3 significantly inhibited migration of both BCC lines at 50 μg/ml for 24 h (p = 0.018 and p = 0.015, respectively). Similarly, significant inhibition of invasion was demonstrated in 4T1 (75 µg/ml, p = 0.016) and MDA-MB-231 (50 µg/ml, p = 0.040) cells compared to the untreated cultures. F3 treatment resulted in reduced tumor growth compared to untreated mice (p Conclusions Our findings suggest that F3 exerts anti-metastatic effects independent of its cytotoxic effects, and these are supported by the increased expression of E-cadherin concurrent with downregulation of MMP-9, MUC1, N-cadherin, Twist, VEGF and vimentin expression in breast cancer.
- Published
- 2019
- Full Text
- View/download PDF